Healthtech Growth Investors & VC Firms
1269 firms in this list, with a median first check of $1.6M. 311 of them lead rounds. Generated from verified public data and updated continuously.
Massachusetts Capital Resource Co.
BostonGrowth–Late Stage
3 people
Norinchukin Capital
TokyoSeed–Late Stage$2M – $333.3M
Rockley Group
OxfordGrowth
3 people
Springboard Growth Capital
New YorkGrowth
5 people
Birk Venture
OsloSeed–Growth
2 people
Hanne Capital
ShanghaiSeed–Growth
2 people
HC NCBR FUND
WarsawSeed–Growth$750K – $16M
2 people
Oscar & Paul Beiersdorf Venture Capital
HamburgSeed–Growth$580K – $5.8M
2 people
Southlight Capital
Mexico CitySeed–Growth
4 people
PRIVEQ Capital Funds
TorontoSeed–Growth
3 people
venn growth partners
TorontoGrowth$10M – $50M
Klein & Partners AG
ZugGrowth$550K – $5.5M
2 people
MCI Capital S.A.
WarsawGrowth–Late Stage$27M – $108M
2 people
W&W brandpool GmbH
KornwestheimPre-Seed–Growth$540K
2 people
JourneyOne Ventures
BoulderPre-Seed–Growth
1 person
Aldrich
McLeanGrowth
3 people
Cathay Health
San FranciscoSeed–Late Stage
3 people
Exit 156 Capital
CollegevilleGrowth
3 people
MIRAIDOOR Co. Ltd.
KyotoPre-Seed–Growth
1 person
Majuven
SingaporeSeed–Growth
4 people
Schouten Investments
AmsterdamGrowth–Late Stage
4 people
Rivus Capital
MunichGrowth$5M – $20M
Tribeca Asset Management
Bogotá D.C.Growth
Unreasonable
Seed–Growth
3 people
Related lists
Growth Investors & VC Firms (4263)Healthtech Investors & VC Firms (4190)Healthtech Seed Investors & VC Firms (3233)Healthtech Investors & VC Firms in North America (2665)Healthtech Investors & VC Firms in United States (2436)Healthtech Series A Investors & VC Firms (2309)Growth Investors & VC Firms in North America (2121)Growth Investors & VC Firms in United States (1837)Growth Investors & VC Firms in Europe (1633)Healthtech Pre-Seed Investors & VC Firms (1468)
Data sourced from public filings and firms' own websites — see our methodology.









































